Latest News
Here's What Happens When You Open a CD Instead of Invest in the S&P 500fool.com
Via The Motley Fool · December 19, 2025
Via MarketBeat · December 19, 2025
Is it a cheap stock or a value trap?
Via The Motley Fool · December 19, 2025
One of these assets is legally in the clear, and the other has issues.
Via The Motley Fool · December 19, 2025
Don't overlook these potential bargain buys -- they may not stay down for long.
Via The Motley Fool · December 19, 2025
Gold is up over 109 percent since the beginning of 2024.
Via Talk Markets · December 19, 2025
This New Product Launch Is Lifting Amesite Shares Premarket — Here’s What Investors Are Watchingstocktwits.com
Via Stocktwits · December 19, 2025
3 Ways the 1% Maintain Their Wealthfool.com
Via The Motley Fool · December 19, 2025
Packaged foods company Conagra Brands (NYSE:CAG) met Wall Streets revenue expectations in Q4 CY2025, but sales fell by 6.8% year on year to $2.98 billion. Its non-GAAP profit of $0.45 per share was 3.2% above analysts’ consensus estimates.
Via StockStory · December 19, 2025
Plaid is one of the hottest fintechs that many expect to eventually go public.
Via The Motley Fool · December 19, 2025
Insurance company Neptune went public in October 2025.
Via The Motley Fool · December 19, 2025
Tenaris SA-ADR offers a strong 4% dividend yield, backed by a decade of reliable payments, high profitability, and an exceptionally sturdy, debt-light balance sheet.
Via Chartmill · December 19, 2025
Winnebago Industries beats Q1 earnings estimates, raises full-year guidance on strong RV segment growth and improved profitability.
Via Chartmill · December 19, 2025
Winnebago Industries has surpassed expectations in the first quarter of fiscal 2026, reporting an EPS of $0.19 and revenue of $702.7 million, both above market forecasts.
Via Talk Markets · December 19, 2025
Nvidia's dominance in the AI accelerator space could slip simply because it can't keep up with demand.
Via The Motley Fool · December 19, 2025
RV Manufacturer Winnebago (NYSE:WGO) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 12.3% year on year to $702.7 million. The company’s full-year revenue guidance of $2.9 billion at the midpoint came in 1.1% above analysts’ estimates. Its non-GAAP profit of $0.38 per share was significantly above analysts’ consensus estimates.
Via StockStory · December 19, 2025
The move comes after Truist updated its long-term outlook for automotive, semiconductor, and artificial intelligence sectors.
Via Stocktwits · December 19, 2025
H&R Block exemplifies quality investing with exceptional profitability, high cash conversion, and a strong dividend, trading at a reasonable valuation.
Via Chartmill · December 19, 2025
Kiwi is looking for more upside after a correction, as we see a sharp and impulsive rebound that can send the price higher from a technical point of view, and by the Elliott wave model.
Via Talk Markets · December 19, 2025
Both XRP and Solana have the potential to turbocharge your portfolio returns.
Via The Motley Fool · December 19, 2025
Via MarketBeat · December 19, 2025
Ives raised Rivian’s price target to $25 from $16, citing the company’s R2 launch and autonomy roadmap in 2026.
Via Stocktwits · December 19, 2025
Next year could be crucial for the company as sales for its only approved treatment could take off.
Via The Motley Fool · December 19, 2025
Sprouts Farmers Market (SFM) presents a classic value investing opportunity, combining strong fundamentals, profitability, and growth with a discounted stock price.
Via Chartmill · December 19, 2025
Cytokinetics is on the cusp of its first FDA approval, analysts say, leading up to the agency's decision date for aficamten.
Via Investor's Business Daily · December 19, 2025